Presenter: Dr. James McCormack Dr. Mike Allan Dr. Nicholas Dugré
In episode 579, Mike and James invite Nicholas Dugré back to the podcast to talk about the evidence around the benefits and harms of a new class of medications for the acute treatment of episodic migraines. Ubrogepant is an oral calcitonin gene-related peptide antagonist. In this case, amazing as it may sound, there are triple…
Latest Podcasts
CFP Podcast: Graphic medicine
Have you ever heard of graphic medicine? Have you wondered what is the difference between a comic and a cartoon? And how is this related to your work in the…
BS Medicine Episode #583: Reducing the risk associated with risk calculators – PART II
In episode 583, Mike and James continue to go over the issues associated with using CVD risk calculators. We talk about some of the limitations, how to think about the…
BS Medicine Episode #582: Reducing the risk associated with risk calculators
In episode 582, Mike and James go over the issues associated with using CVD risk calculators. We talk about where the numbers come from, what they mean, what their limitations…
August 20, 2024
Presenter(s):
Dr. James McCormack Dr. Mike Allan Dr. Nicholas Dugré
Please provide any additional comments (optional).